Drug repurposing strategies targeting core pathways in glioblastoma to address heterogeneity

Synribo (omacetaxine mepesuccinate) - Teva

Ninlaro (ixazomib) - Takeda

temozolomide - Generic mfg.

Farydak (panobinostat) - Secura Bio

A. Marinaro1; D. Osti1; S. Ghouse1,2; L. Fuzio1; F. Lorenzini3; M. Mione3; M. Del Bene1,4; G. Pelicci1,2

Aug 15, 2026